How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

It also explains why there are toilet paper shortages. What is common knowledge, exactly? And where does it come from? We all know we should say “Bless you” when someone sneezes, but why do we do that ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

If you are wondering whether Recursion Pharmaceuticals is a bargain or a value trap at its current share price, this article will walk you through how its valuation stacks up using several common ...

To own Recursion, you need to believe its AI-native platform can keep turning data into real clinical wins and eventual products, not just partnerships. The FAP proof of concept sharpens that near ...